PyroGenesis (PYR.TO), a player in ultra-high temperature processes and engineering innovation, and a plasma-based technology provider to heavy industry & defense, has completed its previously announced non-brokered private placement that was concurrent to a "bought deal" offering, it said Thursday.
The "bought deal" closed previously on June 3, 2026, and combined, the concurrent private placement and the bought deal offering total approximately $6.2 million, the company added.
The concurrent private placement was solely and entirely subscribed by P. Peter Pascali, the company's President and CEO, for 5,882,352 units at a price per Unit of $0.34, for gross proceeds to the company of $2 million, a statement noted.
Each unit consists of one common share and also one common share purchase warrant of the company. Each warrant under the concurrent private placement entitles Pascali to purchase one common share of the company at a price of $0.42. Warrants to be issued to Pascali under the concurrent private placement expire 24 months from the closing date of the offering. All units acquired pursuant to the concurrent private placement will be subject to a hold period of four months pursuant to applicable Canadian securities laws, the statement also noted.
The company said it intends to use the net proceeds from the offering and concurrent private placement for working capital and advancements of contracts and backlog.
Shares in PYR edged down $0.005 to $0.225 in Canada yesterday.